Literature DB >> 21812858

Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.

Takamasa Uekita1, Ryuichi Sakai.   

Abstract

Tumor metastasis is a complex multistep process by which cells from the primary tumor invade tissues, move through the vasculature, settle at distant sites and eventually grow to form secondary tumors. Altered tyrosine phosphorylation signals in cancer cells contribute to a number of aberrant characteristics involved in tumor invasion and metastasis. CUB domain-containing protein 1 (CDCP1) is a substrate of Src family kinases and has been shown to regulate anoikis resistance, migration and matrix degradation during tumor invasion and metastasis in a tyrosine phosphorylation-dependent manner. Knockdown of CDCP1 blocks tumor metastasis or peritoneal dissemination in vivo, without significantly affecting cell proliferation. Moreover, expression levels of CDCP1 are of prognostic value in several cancers. Here, we summarize the studies on CDCP1, focusing on structure and signal transduction, to gain insight into its role in cancer progression. Understanding the signaling pathways regulated by CDCP1 could help establish novel therapeutic strategies against the progression of cancer.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812858     DOI: 10.1111/j.1349-7006.2011.02052.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  25 in total

1.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

2.  Targeting CDCP1 dimerization in triple-negative breast cancer.

Authors:  Heather J Wright; Alice M Police; Olga V Razorenova
Journal:  Cell Cycle       Date:  2016-06-30       Impact factor: 4.534

3.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

4.  Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.

Authors:  Luke J Nelson; Heather J Wright; Nguyen B Dinh; Kevin D Nguyen; Olga V Razorenova; F Scott Heinemann
Journal:  Am J Pathol       Date:  2019-12-13       Impact factor: 4.307

Review 5.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

6.  Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer.

Authors:  Anna Moroz; Yung-Hua Wang; Jeremy M Sharib; Junnian Wei; Ning Zhao; Yangjie Huang; Zhuo Chen; Alexander J Martinko; Jie Zhuo; Shion A Lim; Lydia H Zhang; Youngho Seo; Sean Carlin; Kevin K Leung; Eric A Collisson; Kimberly S Kirkwood; James A Wells; Michael J Evans
Journal:  Clin Cancer Res       Date:  2020-04-27       Impact factor: 12.531

7.  CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

Authors:  Abdullah Alajati; Mariantonietta D'Ambrosio; Martina Troiani; Simone Mosole; Laura Pellegrini; Jingjing Chen; Ajinkya Revandkar; Marco Bolis; Jean-Philippe Theurillat; Ilaria Guccini; Marco Losa; Arianna Calcinotto; Gaston De Bernardis; Emiliano Pasquini; Rocco D'Antuono; Adam Sharp; Ines Figueiredo; Daniel Nava Rodrigues; Jonathan Welti; Veronica Gil; Wei Yuan; Tatjana Vlajnic; Lukas Bubendorf; Giovanna Chiorino; Letizia Gnetti; Verónica Torrano; Arkaitz Carracedo; Laura Camplese; Susumu Hirabayashi; Elena Canato; Gianfranco Pasut; Monica Montopoli; Jan Hendrik Rüschoff; Peter Wild; Holger Moch; Johann De Bono; Andrea Alimonti
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

8.  miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1.

Authors:  Yingbin Hu; Ziyuan Tang; Bonian Jiang; Juying Chen; Zhongpin Fu
Journal:  Oncol Lett       Date:  2017-02-02       Impact factor: 2.967

Review 9.  Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis.

Authors:  Kevin Tan; David Goldstein; Philip Crowe; Jia-Lin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-04       Impact factor: 4.553

10.  CD318 is a ligand for CD6.

Authors:  Gospel Enyindah-Asonye; Yan Li; Jeffrey H Ruth; Danislav S Spassov; Katie E Hebron; Andries Zijlstra; Mark M Moasser; Benlian Wang; Nora G Singer; Huadong Cui; Ray A Ohara; Stephanie M Rasmussen; David A Fox; Feng Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.